Materion director granted 0.75 deferred shares
Materion director Emily M. Liggett reported a small stock award credited to a deferred compensation plan, with updated direct and indirect holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MATERION Corp (symbol: MTRN) is the issuer of record for a Form 4 filing submitted to the SEC. LIGGETT EMILY M reported acquisition or exercise transactions in this Form 4 filing.
MATERION Corp (MTRN) director Emily M. Liggett reported receiving a grant of 0.75 shares of Common Stock on September 4, 2026, credited to a Directors Deferred Compensation Plan and reported as indirectly owned. Following this, she holds 1,272.052 indirect shares and 3,161 direct shares of Materion common stock. No Rule 10b5-1 trading plan is reported for these transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 0.75 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
Common Stock financial
Directors Deferred Comp. Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MTRN director Emily M. Liggett report on this Form 4?
Was a Rule 10b5-1 trading plan used for this MTRN Form 4 transaction?
What price was reported for the Materion (MTRN) stock award to Emily M. Liggett?
AI-generated analysis. How Rhea-AI works. Not financial advice.